Concepedia

Publication | Closed Access

<i>ERCC5</i> Is a Novel Biomarker of Ovarian Cancer Prognosis

DOI

77

Citations

19

References

2008

Year

Christine Walsh, Seishi Ogawa, Hisae Karahashi, Daniel R. Scoles, James Pavelka, Hang Tran, Carl W. Miller, Norihiko Kawamata, Charles Ginther, Judy Dering,
Journal of Clinical Oncology

Abstract

ERCC5 is a novel biomarker of ovarian cancer prognosis and a potential therapeutic target of ovarian cancer response to platinum chemotherapy.

References

YearCitations

Page 1